| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -1.8e-05 | 1 |